Sentinel node biopsy in gastrointestinal-tract cancer

European Journal of Cancer

Volumn 40, Issue 14, 2004, Pages 2022-2032

  Schlag, P M ^a   Bembenek, A ^a   Schulze, T ^a  

^a Section of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

ANUS CARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; ISOTOPE LABELING; LYMPH NODE METASTASIS; MELANOMA; MOLECULAR BIOLOGY; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIOACTIVITY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR IMMUNITY; TUMOR LOCALIZATION;

EID: 4444351162     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.04.033     Document Type: Article

References (114)

1. Cochran A.J., Roberts A.A., Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int. J. Clin. Oncol. 8(3):2003;139-150
2. Borgstein P.J., Meijer S., Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet. 349(9066):1997;1668-1669
3. Tsopelas C., Sutton R. Why certain dyes are useful for localizing the sentinel lymph node. J. Nucl. Med. 43(10):2002;137782
4. Efron P., Knudsen E., Hirshorn S., Copeland E.M. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J. 8(6):2002;396-399
5. McMasters K.M., Wong S.L., Chao C., Woo C., Tuttle T.M., Noyes R.D., et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann. Surg. 234(3):2001;292-299. discussion 9-300
6. Martin R.C., Derossis A.M., Fey J., Yeung H., Yeh S.D., Akhurst T., et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery. 130(3):2001;432-438
7. Bembenek A., Reuhl T., Markwardt J., Schneider U., Schlag P.M. Sentinel lymph node dissection in breast cancer. Swiss Surg. 5(5):1999;217-221
8. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349(9069):1997;1864-1867
9. Aikou T., Higashi H., Natsugoe S., Hokita S., Baba M., Tako S. Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann. Surg. Oncol. 8(9 Suppl):2001;90S-93S
10. Kitagawa Y., Fujii H., Mukai M., Kubota T., Ando N., Watanabe M., et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg. Clin. North Am. 80(6):2000;1799-1809
11. Pijpers R., Borgstein P.J., Meijer S., Krag D.N., Hoekstra O.S., Greuter H.N., et al. Transport and retention of colloidal tracers in regional lymphoscintigraphy in melanoma: influence on lymphatic mapping and sentinel node biopsy. Melanoma Res. 8(5):1998;413-418
12. Mariani G., Moresco L., Viale G., Villa G., Bagnasco M., Canavese G., et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J. Nucl. Med. 42(8):2001;1198-1215
13. Morrow M., Rademaker A.W., Bethke K.P., Talamonti M.S., Dawes L.G., Clauson J., et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 126(4):1999;714-720. discussion 20-2
14. Sutton R., Tsopelas C., Kollias J., Chatterton B.E., Coventry B.J. Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model. Surgery. 131(1):2002;44-49
15. Phillips W.T., Klipper R., Goins B. Use of (99m)Tc-labeled liposomes encapsulating blue dye for identification of the sentinel lymph node. J. Nucl. Med. 42(3):2001;446-451
16. Tanis P.J., Nieweg O.E., Valdes Olmos R.A., Kroon B.B. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J. Am. Coll. Surg. 192(3):2001;399-409
17. Schmid-Schonbein G.W. Microlymphatics and lymph flow. Physiol. Rev. 70(4):1990;987-1028
18. Bergqvist L., Sundberg R., Ryden S., Strand S.E. "The critical colloid dose" in studies of reticuloendothelial function. J. Nucl. Med. 28(9):1987;1424-1429
19. Moghimi S.M., Hawley A.E., Christy N.M., Gray T., Illum L., Davis S.S. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett. 344(1):1994;25-30
20. Broderick-Villa G., Ko A., O'Connell T.X., Guenther J.M., Danial T., DiFronzo L.A. Does tumour burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer J. 8(6):2002;445-450
21. Essner R., Kojima M. Surgical and molecular approaches to the sentinel lymph nodes. Ann. Surg. Oncol. 8(9 Suppl):2001;31S-34S
22. Cochran A.J., Morton D.L., Stern S., Lana A.M., Essner R., Wen D.R. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumour biology and treatment. Mod. Pathol. 14(6):2001;604-608
23. Leong S.P., Peng M., Zhou Y.M., Vaquerano J.E., Chang J.W. Cytokine profiles of sentinel lymph nodes draining the primary melanoma. Ann. Surg. Oncol. 9(1):2002;82-87
24. Romero P., Dunbar P.R., Valmori D., Pittet M., Ogg G.S., Rimoldi D., et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188(9):1998;1641-1650
25. Schrama D., Eggert A.A., Brocker E.B., Pedersen L.O., thor Straten P., Becker J.C. Immunological consequences of the sentinel lymph-node biopsy-lessons from a melanoma patient. Lancet Oncol. 4(7):2003;446-447
26. Matsubara T., Ueda M., Kaisaki S., Kuroda J., Uchida C., Kokudo N., et al. Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer. 89(9):2000;1869-1873
27. Holscher A.H., Bollschweiler E., Schneider P.M., Siewert J.R. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer. 76(2):1995;178-186
28. Feith M., Stein H.J., Siewert J.R. Pattern of lymphatic spread of Barrett's cancer. World J. Surg. 27(9):2003;1052-1057
29. Siewert J.R., Stein H.J. Lymph-node dissection in squamous cell esophageal cancer - who benefits? Langenbecks Arch. Surg. 384(2):1999;141-148
30. Kato H., Miyazaki T., Nakajima M., Takita J., Sohda M., Fukai Y., et al. Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer. 98(5):2003;932-999
31. Yasuda S., Shimada H., Chino O., Tanaka H., Kenmochi T., Takechi M., et al. Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn. J. Clin. Oncol. 33(2):2003;68-72
32. Burian M., Stein H.J., Sendler A., Piert M., Nahrig J., Feith M., et al. Sentinel node detection in Barrett's and cardia cancer. Ann. Surg. Oncol. 11(3 Suppl):2004;255S-258S
33. Sasako M., McCulloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Brit. J. Surg. 82(3):1995;346-351
34. Kampschoer G.H., Maruyama K., van de Velde C.J., Sasako M., Kinoshita T., Okabayashi K. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Brit. J. Surg. 76(9):1989;905-908
35. Bonenkamp J.J., Hermans J., Sasako M., van de Velde C.J. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N. Engl. J. Med. 340(12):1999;908-914
36. Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Brit. J. Cancer. 79(9-10):1999;1522-1530
37. Fass J., Hungs M., Reineke T., Nachtkamp J., Schumpelick V. Prognostic improvement by R1 and R2 lymphadenectomy in stomach carcinoma. Chirurg. 65(10):1994;867-872
38. Siewert J.R., Bottcher K., Roder J.D., Busch R., Hermanek P., Meyer H.J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Brit. J. Surg. 80(8):1993;1015-1018
39. Weinberg J., Greaney E. Identification of regional lymph nodes by means of avital staining dye during surgery of gastric cancer. Surg. Gyn. Obst. 90:1950;561
40. Kosaka T., Ueshige N., Sugaya J., Nakano Y., Akiyama T., Tomita F., et al. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg. Today. 29(8):1999;695-700
41. Palaia R., Cremona F., Delrio P., Izzo F., Ruffolo F., Parisi V. Sentinel node biopsy in gastric cancer. J. Chemother. 11(3):1999;230-231
42. Hiratsuka M., Miyashiro I., Ishikawa O., Furukawa H., Motomura K., Ohigashi H., et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery. 129(3):2001;335-340
43. Ichikura T., Morita D., Uchida T., Okura E., Majima T., Ogawa T., et al. Sentinel node concept in gastric carcinoma. World J. Surg. 26(3):2002;318-322
44. Kitagawa Y., Fujii H., Mukai M., Kubota T., Otani Y., Kitajima M. Radio-guided sentinel node detection for gastric cancer. Brit. J. Surg. 89(5):2002;604-608
45. Miwa K., Kinami S., Taniguchi K., Fushida S., Fujimura T., Nonomura A. Mapping sentinel nodes in patients with early-stage gastric carcinoma. Brit. J. Surg. 90(2):2003;178-182
46. Tonouchi H., Mohri Y., Tanaka K., Konishi N., Ohmori Y., Kobayashi M., et al. Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig. Surg. 20(5):2003;421-427
47. Ryu K.W., Lee J.H., Kim H.S., Kim Y.W., Choi I.J., Bae J.M. Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer. Eur. J. Surg. Oncol. 29(10):2003;895-899
48. Hayashi H., Ochiai T., Mori M., Karube T., Suzuki T., Gunji Y., et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and γ probe-guided techniques. J. Am. Coll. Surg. 196(1):2003;68-74
49. Song X., Wang L., Chen W., Pan T., Zhu H., Xu J., et al. Lymphatic mapping and sentinel node biopsy in gastric cancer. Am. J. Surg. 187(2):2004;270-273
50. Gretschel S, Bembenek A, Ulmer C, Hünerbein M, Markwardt J, Schneider U, et al. Comparision of two different techniques of sentinel lymph node biopsy and the Maruyama computer model for lymph node staging in gastric cancer 2004 [submitted]
51. Shiozawa M., Kawamoto M., Ishiwa N., Rino Y., Takanashi Y., Nakatani Y., et al. Clinical usefulness of intraoperative sentinel-node biopsy in gastric cancer. Hepatogastroenterology. 50(52):2003;1187-1189
52. Uenosono Y., Natsugoe S., Higashi H., Ehi K., Miyazono F., Ishigami S., et al. Evaluation of colloid size for sentinel nodes detection using radioisotope in early gastric cancer. Cancer Lett. 200(1):2003;19-24
53. Kitagawa Y., Ohgami M., Fujii H., Mukai M., Kubota T., Ando N., et al. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann. Surg. Oncol. 8(9 Suppl):2001;86S-89S
54. Investigators IMPACT B2. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 1999, 17(5), 1356-63
55. Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., Goodman P.J., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322(6):1990;352-358
56. Daneker G.W. Jr., Ellis L.M. Colon cancer nodal metastasis: biologic significance and therapeutic considerations. Surg. Oncol. Clin. North Am. 5(1):1996;173-189
57. Goldstein N.S. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am. J. Surg. Pathol. 26(2):2002;179-189
58. Hernanz F., Revuelta S., Redondo C., Madrazo C., Castillo J., Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis. Colon. Rectum. 37(4):1994;373-376. discussion 6-7
59. Sobin L.H., Wittekind Ce. TNM classification of malignent tumours. fifth ed.:1997;Wiley, New York
60. Scott K.W., Grace R.H., Gibbons P. Five-year follow-up study of the fat clearance technique in colorectal carcinoma. Dis. Colon Rectum. 37(2):1994;126-128
61. Cawthorn S.J., Gibbs N.M., Marks C.G. Clearance technique for the detection of lymph nodes in colorectal cancer. Brit. J. Surg. 73(1):1986;58-60
62. Scott K.W., Grace R.H. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Brit. J. Surg. 76(11):1989;1165-1167
63. Rodriguez-Bigas M.A., Maamoun S., Weber T.K., Penetrante R.B., Blumenson L.E., Petrelli N.J. Clinical significance of colorectal cancer: metastases in lymph nodes. < 5 mm in size Ann. Surg. Oncol. 3(2):1996;124-130
64. Greenson J.K., Isenhart C.E., Rice R., Mojzisik C., Houchens D., Martin E.W. Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 73(3):1994;563-569
65. Liefers G.J., Cleton-Jansen A.M., van de Velde C.J., Hermans J., van Krieken J.H., Cornelisse C.J., et al. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med. 339(4):1998;223-228
66. Clarke G., Ryan E., O'Keane J.C., Crowe J., MacMathuna P. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur. J. Gastroenterol. Hepatol. 12(5):2000;549-552
67. Rosenberg R., Hoos A., Mueller J., Baier P., Stricker D., Werner M., et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J. Clin. Oncol. 20(4):2002;1049-1055
68. Isaka N., Nozue M., Doy M., Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin. Cancer Res. 5(8):1999;2065-2068
69. Haboubi N.Y., Abdalla S.A., Amini S., Clark P., Dougal M., Dube A., et al. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int. J. Colorectal Dis. 13(2):1998;99-102
70. Cutait R., Alves V.A., Lopes L.C., Cutait D.E., Borges J.L., Singer J., et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum. 34(10):1991;917-920
71. Jeffers M.D., O'Dowd G.M., Mulcahy H., Stagg M., O'Donoghue D.P., Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J. Pathol. 172(2):1994;183-187
72. Adell G., Boeryd B., Franlund B., Sjodahl R., Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur. J. Surg. 162(8):1996;637-642
73. Broll R., Schauer V., Schimmelpenning H., Strik M., Woltmann A., Best R., et al. Prognostic relevance of occult tumour cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis. Colon Rectum. 40(12):1997;1465-1471
74. Noura S., Yamamoto H., Miyake Y., Kim B., Takayama O., Seshimo I., et al. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin. Cancer Res. 8(3):2002;759-767
75. Choi H.J., Choi Y.Y., Hong S.H. Incidence and prognostic implications of isolated tumour cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis. Colon Rectum. 45(6):2002;750-755
76. Nakanishi Y., Ochiai A., Yamauchi Y., Moriya Y., Yoshimura K., Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology. 57(4):1999;276-280
77. Oberg A., Stenling R., Tavelin B., Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis. Colon Rectum. 41(10):1998;1244-1249
78. Cserni G., Vajda K., Tarjan M., Bori R., Svebis M., Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol. Oncol. Res. 5(4):1999;291-296
79. Joosten J.J., Strobbe L.J., Wauters C.A., Pruszczynski M., Wobbes T., Ruers T.J. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Brit. J. Surg. 86(4):1999;482-486
80. Saha S., Wiese D., Badin J., Beutler T., Nora D., Ganatra B.K., et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann. Surg. Oncol. 7(2):2000;120-124
81. Merrie A.E., van Rij A.M., Phillips L.V., Rossaak J.I., Yun K., McCall J.L. Diagnostic use of the sentinel node in colon cancer. Dis. Colon Rectum. 44(3):2001;410-417
82. Wood T.F., Saha S., Morton D.L., Tsioulias G.J., Rangel D., Hutchinson W. Jr., et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann. Surg. Oncol. 8(2):2001;150-157
83. Saha S., Bilchik A., Wiese D., Espinosa M., Badin J., Ganatra B.K., et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. Ann. Surg. Oncol. 8(9 Suppl):2001;94S-98S
84. Paramo J.C., Summerall J., Poppiti R., Mesko T.W. Validation of sentinel node mapping in patients with colon cancer. Ann. Surg. Oncol. 9(6):2002;550-554
85. Bilchik A.J., Nora D., Tollenaar R.A., van de Velde C.J., Wood T., Turner R., et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur. J. Cancer. 38(7):2002;977-985
86. Kitagawa Y., Watanabe M., Hasegawa H., Yamamoto S., Fujii H., Yamamoto K., et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Dis. Colon Rectum. 45(11):2002;1476-1480
87. Trocha S.D., Nora D.T., Saha S.S., Morton D.L., Wiese D., Bilchik A.J. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J. Gastrointest. Surg. 7(3):2003;340-345
88. Bembenek A, Schneider U, Gretschel S, Ulmer C, Schlag PM. Optimization of stagin in colon cancer using sentinel lymph node biopsy. 2004 [submitted]
89. Bembenek A, Rau B, Moesta T, Markwardt J, Ulmer C, Gretschel S, et al. Sentinel lymph node biopsy in rectal cancer - not yet ready for clinical routine 2004, 135(5), 498-505
90. Fitzgerald T.L., Khalifa M.A., Al Zahrani M., Law C.H., Smith A.J. Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility study. J. Surg. Oncol. 80(1):2002;27-32
91. Tsioulias G.J., Wood T.F., Morton D.L., Bilchik A.J. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch. Surg. 135(8):2000;926-932
92. Mori M., Mimori K., Inoue H., Barnard G.F., Tsuji K., Nanbara S., et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 55(15):1995;3417-3420
93. Rosenberg R., Hoos A., Mueller J., Nekarda H. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Brit. J. Cancer. 83(10):2000;1323-1329
94. Cagir B., Gelmann A., Park J., Fava T., Tankelevitch A., Bittner E.W., et al. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann. Intern. Med. 131(11):1999;805-812
95. Wood T.F., Spirt M., Rangel D., Shen P., Tsioulias G.J., Morton D.L., et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg. Endosc. 15(7):2001;715-719
96. Bouvet M., Mansfield P.F., Skibber J.M., Curley S.A., Ellis L.M., Giacco G.G., et al. Clinical, pathologic, and economic parameters of laparoscopic colon resection for cancer. Am. J. Surg. 176(6):1998;554-558
97. Stage J.G., Schulze S., Moller P., Overgaard H., Andersen M., Rebsdorf-Pedersen V.B., et al. Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Brit. J. Surg. 84(3):1997;391-396
98. Bilchik A.J., Trocha S.D. Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update. Cancer Control. 10(3):2003;219-223
99. Wong J.H., Steineman S., Calderia C., Bowles J., Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann. Surg. 233(4):2001;515-521
100. Ryan D.P., Compton C.C., Mayer R.J. Carcinoma of the anal canal. N. Engl. J. Med. 342(11):2000;792-800
101. Boman B.M., Moertel C.G., Mj O.C., Scott M., Weiland L.H., Beart R.W., et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 54(1):1984;114-125
102. Papillon J., Montbarbon J.F. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis. Colon Rectum. 30(5):1987;324-333
103. Golden G.T., Horsley III J.S. Surgical management of epidermoid carcinoma of the anus. Am. J. Surg. 131(3):1976;275-280
104. Gerard J.P., Chapet O., Samiei F., Morignat E., Isaac S., Paulin C., et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer. 92(1):2001;77-84
105. Gordon P.H. Current status - perianal and anal canal neoplasms. Dis. Colon Rectum. 33(9):1990;799-808
106. Stearns M.W. Jr., Urmacher C., Sternberg S.S., Woodruff J., Attiyeh F. Cancer of the anal canal. Curr. Probl. Cancer. 4(12):1980;1-44
107. Pintor M.P., Northover J.M., Nicholls R.J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Brit. J. Surg. 76(8):1989;806-810
108. Wade D.S., Herrera L., Castillo N.B., Petrelli N.J. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg. Gynecol. Obstet. 169(3):1989;238-242
109. Perera D., Pathma-Nathan N., Rabbitt P., Hewett P., Rieger N. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis. Colon Rectum. 46(8):2003;1027-1029. discussion 30-1
110. Damin D.C., Rosito M.A., Gus P., Spiro B.L., Amaral B.B., Meurer L., et al. Sentinel lymph node procedure in patients with epidermoid carcinoma of the anal canal: early experience. Dis. Colon Rectum. 46(8):2003;1032-1037
111. Ulmer C., Bembenek A., Gretschel S., Markwardt J., Koswig S., Schneider U., et al. Refined staging by sentinel lymph node biopsy to individualize therapy in anal cancer. Ann. 11(3 Suppl):2004;259S-262S
112. Ohta T., Kitagawa H., Kayahara M., Kinami S., Ninomiya I., Fushida S., et al. Sentinel lymph node navigation surgery for pancreatic head cancers. Oncology. 10(2):2003;315-319
113. Kane J.Mr., Kahlenberg M.S., Rodriguez-Bigas M.A., Gibbs J.F., Petrelli N.J. Intraoperative hepatic lymphatic mapping in patients with liver metastases from colorectal carcinoma. Am. Surg. 68(9):2002;745-750
114. Gould E., Winship T., Philbin P., Kerr H. Observations on a sentinel node in cancer of the parotid. Cancer. 13:1960;77-78